These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9467685)

  • 1. Gene therapy for rheumatoid arthritis. Theoretical considerations.
    Chernajovsky Y; Annenkov A; Herman C; Triantaphyllopoulos K; Gould D; Dreja H; Moyes SP; Croxford JL; Mageed RA; Podhajcer OL; Baker D
    Drugs Aging; 1998 Jan; 12(1):29-41. PubMed ID: 9467685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy in rheumatoid polyarthritis: perspectives].
    Bessis N; Boissier MC
    Presse Med; 1998 Mar; 27(12):580-2. PubMed ID: 9767955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy approaches for treating rheumatoid arthritis.
    Ghivizzani SC; Oligino TJ; Glorioso JC; Robbins PD; Evans CH
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S288-99. PubMed ID: 11039782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives].
    Jorgensen C
    Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for patients with rheumatoid arthritis.
    Bessis N; Boissier MC
    Joint Bone Spine; 2006 Mar; 73(2):169-76. PubMed ID: 16226478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of gene therapy for rheumatoid arthritis.
    Gaddy DF; Robbins PD
    Curr Rheumatol Rep; 2008 Oct; 10(5):398-404. PubMed ID: 18817645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors.
    Wieser C; Stumpf D; Grillhösl C; Lengenfelder D; Gay S; Fleckenstein B; Ensser A
    Gene Ther; 2005 Mar; 12(5):395-406. PubMed ID: 15647772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
    Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in molecular therapeutic approaches for rheumatoid arthritis.
    Woods A; Hobson P; Klavinskis LS
    Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy in rheumatoid arthritis: Strategies to select therapeutic genes.
    Zavvar M; Assadiasl S; Soleimanifar N; Pakdel FD; Abdolmohammadi K; Fatahi Y; Abdolmaleki M; Baghdadi H; Tayebi L; Nicknam MH
    J Cell Physiol; 2019 Aug; 234(10):16913-16924. PubMed ID: 30809802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy in rheumatoid arthritis: new aspects].
    Pundt N; Peters MA; Wunrau C; Pap T
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of cellular gene therapy for rheumatoid arthritis.
    Nakajima A
    Mod Rheumatol; 2006; 16(5):269-75. PubMed ID: 17039306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
    Prud'homme GJ
    J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
    Adriaansen J; Vervoordeldonk MJ; Tak PP
    Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for arthritis.
    Robbins PD; Evans CH; Chernajovsky Y
    Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy works in animal models of rheumatoid arthritis...so what!
    van de Loo FA; Geurts J; van den Berg WB
    Curr Rheumatol Rep; 2006 Oct; 8(5):386-93. PubMed ID: 16973113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.